Literature DB >> 34874429

Racial and Ethnic Representation in US Clinical Trials of New Drugs and Biologics, 2015-2019.

Milena Lolic1, Richardae Araojo1, Melvyn Okeke2, Janet Woodcock1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34874429      PMCID： PMC8652601          DOI： 10.1001/jama.2021.16680

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   157.335


× No keyword cloud information.
  2 in total

1.  Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: have we made progress?

Authors:  Stacie E Geller; Abby Koch; Beth Pellettieri; Molly Carnes
Journal:  J Womens Health (Larchmt)       Date:  2011-02-25       Impact factor: 2.681

2.  Demographic diversity of participants in Pfizer sponsored clinical trials in the United States.

Authors:  Melinda Rottas; Peter Thadeio; Rachel Simons; Raven Houck; David Gruben; David Keller; David Scholfield; Koshika Soma; Brian Corrigan; Annette Schettino; Patrick J McCann; Marie-Pierre Hellio; Kannan Natarajan; Rob Goodwin; Judy Sewards; Peter Honig; Rod MacKenzie
Journal:  Contemp Clin Trials       Date:  2021-04-30       Impact factor: 2.226
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.